learning

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic pancreatic cancer (mPDAC) treated with elraglusib June 20,…

8 months ago

AMITY SCHOOL OF FASHION TECHNOLOGY SHOWCASES AT DELHI TIMES FASHION WEEK 2025

DELHI, May 29, 2025 /PRNewswire/ -- Students from Amity School of Fashion Technology participated in the prestigious Delhi Times Fashion…

9 months ago